I can't tell you how manay times since KOS was bought I have used the success story of KOS to explain what good looks like. It really has been a bench mark on what can happen if you work hard, have faith, and have good leadership. I know not everyone has such great memories, but in the companies that I have been involved with since then I have not seen anything even remotely close.
Anonymous
Guest
Anonymous
Guest
Anonymous
Guest
go fuck yourself
Nice, glad you have finally gotten over being canned for not working. How's unemployment treating you, you must love Obama since he's allowing you to sit on your Arse for almost 2 years now to collect when you get fired from your next job. Sorry your bitter. It was a great company and had some great people, obviously you must not have been one of them.
The Legend
Anonymous
Guest
Anonymous
Guest
I miss KOS. Once in a lifetime. Glad I had the opportunity. Yes, a great story to tell. Anyone find a similar company out there anywhere? If so, jump on it.
Anonymous
Guest
Anonymous
Guest
I miss KOS, and I was on the contract force. I worked with professionals that wanted to get the job done.
Anonymous
Guest
Anonymous
Guest
I loved my time at KOS too. Was there from launch in 97 until 03. We had fun, worked hard, and had lots of great people. Jaharis had dinner with us at one of our meetings. What a great guy. I left for a good biotech opportunity but left behind lots of friends. Good times.
Anonymous
Guest
Anonymous
Guest
Nice, glad you have finally gotten over being canned for not working. How's unemployment treating you, you must love Obama since he's allowing you to sit on your Arse for almost 2 years now to collect when you get fired from your next job. Sorry your bitter. It was a great company and had some great people, obviously you must not have been one of them.
The Legend
There is only one legend and you my friend are not it......!
The Legend
Anonymous
Guest
Anonymous
Guest
The TRUE Kos Story finally unveiled
December 8, 2010 News | Business linked to kickback scheme — Baton Rouge, LA
Kos Pharmaceuticals Inc. paid kickbacks to unnamed Louisiana physicians who wrote prescriptions for two of the manufacturer’s cholesterol medications, Advicor and Niaspan, the U.S. Attorney’s Office charged Tuesday in Baton Rouge.
Kos immediately agreed to pay more than $41 million to end its corporate liability for the alleged crime, the Justice Department announced in Washington, D.C.
The charge in Baton Rouge refers to three unnamed Kos executives who allegedly met with two unnamed cardiothoracic surgeons for a dinner in Houma before the surgeons began receiving kickbacks that eventually totaled $323,700.
Those executives and surgeons may remain unnamed in Baton Rouge, First Assistant U.S. Attorney Walt Green said late Tuesday.
“In our district, the investigation is completed,” Green said for the Middle District of Louisiana.
The Justice Department announcement in Washington said the settlement resolved both the criminal case and two civil suits filed by former Kos employees who acted as whistleblowers to expose the kickbacks.
Those whistleblowers will share payments totaling $6.4 million of Kos’ $41 million settlement, Justice Department officials announced.
Another $4.4 million will be paid to Louisiana’s Medicaid program, according to the Justice Department’s written statement. The remaining $30.2 million will go to the federal
So who were the whistle=blowers and was this Sancho's Sceme?
December 8, 2010 News | Business linked to kickback scheme — Baton Rouge, LA
Kos Pharmaceuticals Inc. paid kickbacks to unnamed Louisiana physicians who wrote prescriptions for two of the manufacturer’s cholesterol medications, Advicor and Niaspan, the U.S. Attorney’s Office charged Tuesday in Baton Rouge.
Kos immediately agreed to pay more than $41 million to end its corporate liability for the alleged crime, the Justice Department announced in Washington, D.C.
The charge in Baton Rouge refers to three unnamed Kos executives who allegedly met with two unnamed cardiothoracic surgeons for a dinner in Houma before the surgeons began receiving kickbacks that eventually totaled $323,700.
Those executives and surgeons may remain unnamed in Baton Rouge, First Assistant U.S. Attorney Walt Green said late Tuesday.
“In our district, the investigation is completed,” Green said for the Middle District of Louisiana.
The Justice Department announcement in Washington said the settlement resolved both the criminal case and two civil suits filed by former Kos employees who acted as whistleblowers to expose the kickbacks.
Those whistleblowers will share payments totaling $6.4 million of Kos’ $41 million settlement, Justice Department officials announced.
Another $4.4 million will be paid to Louisiana’s Medicaid program, according to the Justice Department’s written statement. The remaining $30.2 million will go to the federal
So who were the whistle=blowers and was this Sancho's Sceme?
Anonymous
Guest
Anonymous
Guest
Oh, Sancho for sure....but would love the know the other guilty parties! If anyone knows who the whistleblowers were, give it up....brutha needs to hit 'em up for a loan! LOL
Anonymous
Guest
Anonymous
Guest
what about all the questionable stuff that went on in NYC - or is that still working its way through the "system"?
Talk about buying the business.....
Talk about buying the business.....
Anonymous
Guest
Anonymous
Guest
<< ..Kos Pharmaceuticals — now a unit of Abbott Labs (ABT) — gave kickbacks to doctors for “chart pull” sessions, in which doctors’ assistants went through confidential medical records looking for patients who could be switched to Abbott’s Niaspan anti-cholesterol drug, according to court documents in a $41 million settlement the Department of Justice announced yesterday.
Drug companies gaining illicit access to private medical records is a sinister trend in pharmaceutical marketing: Amgen has been accused three times of doing the same thing. Gaining access to patients’ data wihout their consent is a violation of the federal Health Insurance Portability and Accountability Act of 1996. But it appears that the goldmine that patients’ records represent to drug companies was too much of a temptation for Abbott’s Kos sales force in Louisiana.
According to one of the complaints behind the settlement, sales executives at Kos paid a doctor to go through 202 of his patient records, looking for Niaspan candidates (click to enlarge):
The effort had a certain cajun flavor to it, the complaint alleged. “Nobody cares about the merits of your product down here,” one sales chief is quoted as saying. “We’re gonna go back to the old ways of doing business at Kos”:
Those sales chiefs are probably identifiable to anyone who worked at Kos in the 2002-2004 timeframe.* As identified in the criminal information sheet filed by the feds, they are:
Executive A, the vp in charge of the Kos nationwide salesforce.
Executive B, the director in charge of the Kos sales force southeastern region.
Executive C, the manager in charge of the Kos sales force New Orleans district, which included all of Louisiana.
Their names are likely inside one of the whistleblower complaints behind the settlement, but that lawsuit is currently still sealed. One potential reason the feds kept their names out of the settlement papers, and kept the seal on the case, is because it is considering further action.
The Kos folks were generous with their money. They paid $250 for every 10 new Niaspan patients doctors recruited, and $750 for 20 more. In 2002 and 2003, physicians “A” and “B” received $214,500 in the form of continuing medical education fees from Kos. In return, the docs wrote more than 1,000 prescriptions a year, sometimes at the rate of more than three per day, and promoted the drug to other doctors who attended their classes.
Abbott bought Kos in 2006 to acquire Niaspan, which currently makes $250 million per quarter in sales. Presumably the new parent company has since introduced some adult supervision down on the Bayou.
Drug companies gaining illicit access to private medical records is a sinister trend in pharmaceutical marketing: Amgen has been accused three times of doing the same thing. Gaining access to patients’ data wihout their consent is a violation of the federal Health Insurance Portability and Accountability Act of 1996. But it appears that the goldmine that patients’ records represent to drug companies was too much of a temptation for Abbott’s Kos sales force in Louisiana.
According to one of the complaints behind the settlement, sales executives at Kos paid a doctor to go through 202 of his patient records, looking for Niaspan candidates (click to enlarge):
The effort had a certain cajun flavor to it, the complaint alleged. “Nobody cares about the merits of your product down here,” one sales chief is quoted as saying. “We’re gonna go back to the old ways of doing business at Kos”:
Those sales chiefs are probably identifiable to anyone who worked at Kos in the 2002-2004 timeframe.* As identified in the criminal information sheet filed by the feds, they are:
Executive A, the vp in charge of the Kos nationwide salesforce.
Executive B, the director in charge of the Kos sales force southeastern region.
Executive C, the manager in charge of the Kos sales force New Orleans district, which included all of Louisiana.
Their names are likely inside one of the whistleblower complaints behind the settlement, but that lawsuit is currently still sealed. One potential reason the feds kept their names out of the settlement papers, and kept the seal on the case, is because it is considering further action.
The Kos folks were generous with their money. They paid $250 for every 10 new Niaspan patients doctors recruited, and $750 for 20 more. In 2002 and 2003, physicians “A” and “B” received $214,500 in the form of continuing medical education fees from Kos. In return, the docs wrote more than 1,000 prescriptions a year, sometimes at the rate of more than three per day, and promoted the drug to other doctors who attended their classes.
Abbott bought Kos in 2006 to acquire Niaspan, which currently makes $250 million per quarter in sales. Presumably the new parent company has since introduced some adult supervision down on the Bayou.
Anonymous
Guest
Anonymous
Guest
The TRUE Kos Story finally unveiled
December 8, 2010 News | Business linked to kickback scheme — Baton Rouge, LA
Kos Pharmaceuticals Inc. paid kickbacks to unnamed Louisiana physicians who wrote prescriptions for two of the manufacturer’s cholesterol medications, Advicor and Niaspan, the U.S. Attorney’s Office charged Tuesday in Baton Rouge.
Kos immediately agreed to pay more than $41 million to end its corporate liability for the alleged crime, the Justice Department announced in Washington, D.C.
The charge in Baton Rouge refers to three unnamed Kos executives who allegedly met with two unnamed cardiothoracic surgeons for a dinner in Houma before the surgeons began receiving kickbacks that eventually totaled $323,700.
Those executives and surgeons may remain unnamed in Baton Rouge, First Assistant U.S. Attorney Walt Green said late Tuesday.
“In our district, the investigation is completed,” Green said for the Middle District of Louisiana.
The Justice Department announcement in Washington said the settlement resolved both the criminal case and two civil suits filed by former Kos employees who acted as whistleblowers to expose the kickbacks.
Those whistleblowers will share payments totaling $6.4 million of Kos’ $41 million settlement, Justice Department officials announced.
Another $4.4 million will be paid to Louisiana’s Medicaid program, according to the Justice Department’s written statement. The remaining $30.2 million will go to the federal
So who were the whistle=blowers and was this Sancho's Sceme?
Did this happen under Tilbury's watch?
Anonymous
Guest
Anonymous
Guest
Was there from start to finish. Loved it. Miss it a lot. What a great ride.
Anonymous
Guest
Anonymous
Guest
Yes, it was a fantastic ride. Once in a lifetime.
Anonymous
Guest
Anonymous
Guest
I remember all the nice rides I enjoyed at the NSMs....shweet!
Anonymous
Guest
Anonymous
Guest
Anonymous
Guest
I remember all the nice rides I enjoyed at the NSMs....shweet!
Yeah....those were the ho, ho, ho's you paid.